Related Experiment Videos
[Magnetic resonance imaging of cystic ovarian tumors]
Rinsho Hoshasen. Clinical Radiography
|March 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
5-HT3 receptor antagonists. 1. New quinoline derivatives.
Journal of medicinal chemistry·1992
New bronchodilators. II. 3H-imidazo[4,5-c]quinolin-4(5H)-ones.
Chemical & pharmaceutical bulletin·1992
Experimental chemotherapy for xenograft cell lines of human bile duct and gall bladder cancers in nude mice.
Journal of surgical oncology·1992
Site of attachment of mercuribenzoate in crystals of an actin:DNase I complex.
Journal of biochemistry·1992
[A case of tuberculous arthritis of shoulder].
Rinsho hoshasen. Clinical radiography·1990
[Three cases of alveolar soft part sarcoma and MRI findings].
Rinsho hoshasen. Clinical radiography·1990
[Metastasis of uterine cervical cancer to the biceps muscle of right upper arm; report of a case].
Rinsho hoshasen. Clinical radiography·1990
[A case of aplasia of the pancreatic body and tail accidentally detected on computed tomography].
Rinsho hoshasen. Clinical radiography·1990
[Increased gallium-67 citrate uptake in the breast of a patient with gynecomastia].
Rinsho hoshasen. Clinical radiography·1990
[Hemangioma of the hypopharynx; a case report and value of MRI].
Rinsho hoshasen. Clinical radiography·1990
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026